Please try another search
For the three months ended 31 March 2022, KMPharmaceutical Co Ltd revenues decreased 12% to W4.73B. Net loss totaled W39.9M vs. income of W18.6M. Revenues reflect Products-Adult Beauty Care segment decrease of 46% to W736M, Merchandises-Other segment decrease of 94% to W14M, Other segment decrease from W1.1B to W0K. Net loss reflects Commission Paid increase of 58% to W334.7M (expense).
Period Ending: | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
---|---|---|---|---|
Total Revenue | 3369.99 | 4727.39 | 6451.54 | 5374.53 |
Gross Profit | 639.23 | 1133.91 | 2264.9 | 1077.01 |
Operating Income | -455.73 | -110.14 | 914.04 | -139.75 |
Net Income | -480.28 | -39.88 | 47.88 | -406.96 |
Period Ending: | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
---|---|---|---|---|
Total Assets | 53996.92 | 51231.74 | 53067.33 | 50692.07 |
Total Liabilities | 14219.55 | 10974.1 | 12769.8 | 10185.94 |
Total Equity | 39777.37 | 40257.64 | 40297.53 | 40506.14 |
Period Ending: | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -361.04 | 1046.23 | 2267.19 | 1463.58 |
Cash From Investing Activities | -5355.25 | -108.17 | -8058.37 | -2949.41 |
Cash From Financing Activities | 4296.59 | -1535.23 | 2194.9 | -234.17 |
Net Change in Cash | -1419.08 | -597.8 | -3595.57 | -1719.53 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review